Kraken, X-energy, Kailera and Lightelligence file IPOs targeting public markets
Four companies moved toward public markets this week with different size targets and strategic goals. Kraken submitted a confidential U.S. IPO filing, with market reports valuing the exchange at about $13.3 billion. X-energy began an investor roadshow and set a price range of $16 to $19 per share, targeting roughly $800 million to fund deployment of small modular reactors.
Kailera Therapeutics filed for a $500 million IPO, offering 33.33 million shares at $14 to $16 per share. Lightelligence is pursuing a Hong Kong listing and seeks $300 million to $400 million, after a prior valuation near $1.1 billion and reported revenue growth of 66.9 percent annually through 2025. Investors should note differences in risk profiles and capital needs across the four companies.
Key Takeaways
- Kraken submitted a confidential U.S. IPO filing with an estimated valuation of about $13.3 billion.weex.com
- X-energy set a proposed IPO price range of $16 to $19 per share, implying proceeds of up to roughly $814 million at the top end.iposcoop.com
- Kailera Therapeutics filed to raise $500 million, offering 33.33 million shares at $14 to $16 per share under the proposed ticker KLRA.techcrunch.com
- Lightelligence is pursuing a Hong Kong IPO to raise $300 million to $400 million, after a 7.8 billion yuan (about $1.1 billion) valuation and revenue that grew at a 66.9 percent compound annual rate to 106 million yuan in 2025.techinasia.com
Affected Companies
Sources
Chinese AI Startup Lightelligence Eyes Hong Kong IPO
Tech in Asia
“Reported that Lightelligence passed a Hong Kong listing hearing, seeks $300 million to $400 million in an IPO, held a prior valuation near 7.8 billion yuan and reported 66.9 percent CAGR to 106 million yuan revenue in 2025.”
Amazon-Backed Nuclear Startup X-energy Files for $800 Million IPO to Deploy Reactors
TechCrunch
“Reported that X-energy began an investor roadshow, set a $16 to $19 per share range, and noted Amazon as a major backer which led a $500 million round and pledged large power purchases.”
Obesity-Focused Kailera Therapeutics Launches $500 Million IPO for GLP-1 Treatments
IPOScoop
“Reported that Kailera filed an S-1 to raise $500 million, offering 33.33 million shares at $14 to $16 per share under proposed symbol KLRA.”